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OBJECTIVE: To identify the independent variables associated with death within 4 days after the first sepsis-
induced organ dysfunction.
METHODS: In this prospective observational study, severe sepsis and septic shock patients were classified into 3
groups: Group 1, survivors; Group 2, late non-survivors; and Group 3, early non-survivors. Early death was
defined as death occurring within 4 days after the first sepsis-induced organ dysfunction. Demographic, clinical
and laboratory data were collected and submitted to univariate and multinomial analyses.
RESULTS: The study included 414 patients: 218 (52.7%) in Group 1, 165 (39.8%) in Group 2, and 31 (7.5%) in
Group 3. A multinomial logistic regression analysis showed that age, Acute Physiology and Chronic Health
Evaluation II score, Sepsis-related Organ Failure Assessment score after the first 24 hours, nosocomial infection,
hepatic dysfunction, and the time elapsed between the onset of organ dysfunction and the sepsis diagnosis
were associated with early mortality. In contrast, Black race and a source of infection other than the urinary
tract were associated with late death. Among the non-survivors, early death was associated with Acute
Physiology and Chronic Health Evaluation II score, chronic renal failure, hepatic dysfunction Sepsis-related
Organ Failure Assessment score after 24 hours, and the duration of organ dysfunction.
CONCLUSION: Factors related to patients’ intrinsic characteristics and disease severity as well as the promptness
of sepsis recognition are associated with early death among severe septic patients.
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& INTRODUCTION
Severe sepsis remains a challenge for healthcare providers
because it carries a high mortality rate despite increased
resource allocation from both health institutions and govern-
ments (1–5). For these reasons, many researchers have
devoted their efforts to finding efficient interventions (6,7).
There are few published data regarding the potential risk
factors associated with early death in sepsis patients, and
the concept of ‘‘early’’ is inconsistent (8–10). Some authors
have attempted to construct models, which included
patients’ general characteristics (11) or only coagulation
factors (12), to predict short-term mortality in sepsis.
However, these authors used either 7 days or 14 days as
the definition of short term. Another study only analyzed
patients who were admitted to the emergency department
without shock and reported a progression to shock in 17.8%
of patients in the first 48 hours. However, they did not
address early mortality (13).
Therefore, we hypothesized that some factors are linked
to early death and that patients at risk for early death could
be identified using clinical and laboratory data collected in
the first days after intensive care unit (ICU) admission.
Thus, the purpose of this study was to identify the variables
that were independently associated with death within 4
days after the first sepsis-induced organ dysfunction.
& METHODS AND MATERIALS
Design and setting
This prospective cohort study was conducted at 3 mixed
medical/surgical Brazilian intensive care units (1 public, 2
private; 87 total beds) from January 2007 through March
2009. All the study procedures were in accordance with the
Copyright  2013 CLINICS – This is an Open Access article distributed under
the terms of the Creative Commons Attribution Non-Commercial License (http://
creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-
commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited.
No potential conflict of interest was reported.
DOI: 10.6061/clinics/2013(05)02
CLINICAL SCIENCE
586
ethical standards of the revised Helsinki Declaration (1983).
The Research and Ethics Committee from each institution
approved the study (Federal University of Sao Paulo: 1477/
06; Sirio Libanes Hospital: HSL2006/27; Hospital Israelita
Albert Einstein: 07/549). All patients or their closest relatives
signed informed consent forms allowing data collection.
Inclusion/exclusion criteria and definitions
All patients older than 18 years of age diagnosed with
severe sepsis or septic shock, as previously defined (14),
were prospectively included. Briefly, patients were eligible
for inclusion if they had 2 or more signs of systemic
inflammatory response syndrome secondary to a known or
suspected infection and at least 1 sepsis-induced organ
dysfunction. Patients were excluded if they were pregnant
or if their physicians were not committed to full life support.
Sepsis-induced organ dysfunction was defined by one of
the following symptoms: hypotension, arterial oxygen
partial pressure/oxygen inspiratory fraction (PaO2/FiO2)
ratio #300, lactate level $1.5 times the reference value and
base deficit .5, bilirubin level .2 times the reference value,
urine output #0.5 ml/kg/hour after an adequate volume
replacement or the need for renal replacement therapy,
platelet count#100,000 mm3 or a 50% decrease from the last
3 days’ values, and a reduced level of consciousness. Septic
shock was defined as volume-refractory hypotension with a
need for vasopressors. The time for sepsis diagnosis was
defined as the number of hours elapsed between the onset
of the first dysfunction and its recognition or management
by the healthcare provider. We defined sepsis recognition as
the record of a sepsis hypothesis in the patient’s chart. To
identify the moment of organ dysfunction, the patient’s
chart was carefully reviewed to determine the first record of
hypotension, reduced level of consciousness or low urine
output as well as the first laboratory sampling time whose
results fulfilled the respiratory, metabolic, coagulation or
hepatic criteria for organ dysfunction. For patients admitted
from the emergency department who already had severe
sepsis criteria, we used the time of triage.
Patients were classified into 3 groups according to their
outcomes: survivors (Group 1), late death (Group 2), and
early death (Group 3). Early death was defined as death
occurring within 4 days after the onset of the first sepsis-
induced organ dysfunction.
Data collection
Demographic data were collected at inclusion, as were the
Acute Physiological and Chronic Health Evaluation
(APACHE II) and Sequential Organ Failure Assessment
(SOFA) scores (SOFAD0). SOFA scores were also determined
on Day 1 (SOFA D1) and Day 3 (SOFA D3). The change in
SOFA score was calculated by subtracting SOFA D0 from
SOFA D3 (DSOFA D3) and SOFA D1 (DSOFA D1). Clinical
and outcome features, including compliance to the 6-hour
and 24-hour Surviving Sepsis Campaign (SSC) bundles, were
registered as proposed by the Campaign (15). We did not
record data on activated protein C or low-dose steroid
adherence because of the controversial aspects related to their
use. The patients were followed until hospital discharge or
for 60 days, and ICU and hospital outcomes were recorded.
Statistics
Continuous data were presented as medians and inter-
quartile ranges, and categorical variables were reported as
the number (%). The normality of continuous variables was
determined with the Kolmogorov-Smirnov test. The 3
groups were compared regarding the mortality risk factors.
The non-parametric Kruskal-Wallis test, with the Muller-
Dunn post-test, were used for non-normally distributed
variables. The chi-squared likelihood ratio test or Pearson’s
chi-squared test was used, as appropriate, and partitioning
of chi-square was performed if needed.
We performed a multinomial logistic regression analysis
to allow for simultaneous comparisons among the 3 studied
groups. For a variable to be included in the model, we
transformed all the continuous variables into categorical
variables according to the best cut-off point for early
mortality prediction in the receiver operating characteristic
(ROC) curve. For all the SOFA scores, we used the same cut-
off value based on the ROC curve of SOFA scores at
admission. For DSOFA D3 and DSOFA D1, any negative
value was considered an improvement, while all positive or
zero values were considered a worsening outcome.
Variables associated with early death at the 0.2 level in the
univariate analysis were included in the model, except for
those with more than 50 missing cases or those not
applicable for all patients. A step-by-step method was used
to select the significant variables. To identify the risks
factors for early and late death compared with the
survivors, Group 1 was considered the reference group.
To identify the risk factors related to early death among
non-survivors, Group 2 (late death) was the reference
group. A p-value ,0.05 for any of the groups being
compared was considered to retain a specific variable in
the analysis. After the selection, the results were presented
as odds ratios and 95% confidence intervals (CI).
Statistical analyses were performed using PASW Statistics
18 for Windows (SPSS Inc., Chicago, USA), and all the tests
were two tailed.
& RESULTS
Basic characteristics of septic patients
A total 414 septic patients were included in the study: 218
(52.7%) in Group 1, 165 (39.8%) in Group 2, and 31 (7.5%) in
Group 3. We followed all the patients until hospital
discharge or death. Among the deaths, 15.8% occurred in
the first 4 days. All demographic and baseline character-
istics are shown in Table 1.
Factors associated with early and late hospital
mortality – univariate analysis
In the univariate analysis, the APACHE II and SOFA
scores at admission were associated with both early and late
mortality. However, more patients had high scores in the
early mortality group compared to those with late mortality.
The severity of organ dysfunction was higher in non-
survivors, and the percentage of higher scores at Day 1 and
Day 3 clearly distinguished between early and late death.
The worsening of dysfunction, as measured by both DSOFA
D1 and DSOFA D3, occurred more frequently in the non-
survivors, regardless of the time of death (Table 1).
Respiratory dysfunction was a marker of early and late
death, while hepatic dysfunction was more prevalent only
in the early death group. We found higher lactate levels in
the patients with hepatic dysfunction (17.4, 11.1–29.0 vs.
23.5, 14.2–47.3, p= 0.013). Late recognition of organ dysfunc-
tion (.1 hour) was more prevalent in non-survivors. There
CLINICS 2013;68(5):586-591 Determinants of early death in sepsis
Machado FR et al.
587
were no differences between groups in compliance with
any indicator of the SSC-6 h bundle or glycemic control
(Table 2).
Factors associated with early and late hospital
mortality – multinomial analysis
The covariance analysis using the Jaccard test detected a
high degree of colinearity between the presence of shock
and SOFA D1 (r = 0.764), as well as between respiratory
dysfunction and a pulmonary source of infection (r = 0.724).
Thus, on the basis of their p values in the univariate
analysis, we excluded both septic shock (p= 0.138) and a
pulmonary source of infection (p= 0.048) from the multi-
nomial analysis.
The multinomial analysis revealed that the patient age,
SOFA score after the first 24 hours, nosocomial infection,
and duration of organ dysfunction were associated with
both early and late mortality. However, the odds ratios were
Table 1 - Patient demographics and infection characteristics according to the survival group.
Variable Group 1 (n =218) Group 2 (n= 165) Group 3 (n = 31) p-value+
Age (years) 62.0 (46.0–77.0) 69.0 (54.0–78.0)*** 69.0 (54.0–77.0)* 0.069
Age $52 150 (68.8), 137 (83.0)*** 27 (87.1)* 0.001
Gender
Female 94 (43.1) 67 (40.6) 9 (29.0) 0.324
Male 124 (56.9) 98 (59.4) 22 (71.0)
Race
Black 22 (10.1) 35 (21.2)** 7 (22.6) 0.030
White 187 (85.8) 124 (75.2) 22 (71.0)
Other
APACHE II score 17.0 (13.0–21.0) 19.0 (15.0–24.0)* 22.0 (15.0–26.0)* 0.0002
APACHE $22 52 (23.9) 54 (32.7) 16 (51.6)*{ 0.004
SOFA score
SOFA D0 6.0 (4.0–9.0) 8.0 (5.0–10.0)* 9.0 (8.0–11.0)* ,0.00001
SOFA D0 $8 81 (37.5) 90 (54.5)*** 25 (80.6)*** {{ ,0.00001
SOFA D1 6.0 (4.0–8.0) 8.0 (6.0–11.0)* 10.0 (8.0–12.0)* ,0.0001
SOFA D1 $8 73 (34.3) 101 (61.2)*** 23 (85.2)*** {{ ,0.0001
SOFA D3 5.0 (2.0–8.0) 8.0 (6.0–11.0)* 9.0 (8.0–12.0)* ,0.0001
SOFA D3 $8 50 (26.5) 92 (56.8)*** 11 (84.6)*** { ,0.0001
DSOFA D1 0.0 (22.0–1.0) 0.0 (21.0–2.0)* 1.0 (0.0–2.0)* ,0.0001
Worsening DSOFA D1 123 (57.7) 117 (70.9)** 21 (77.8)* ,0.009
DSOFA D3 21.0 (23.0–0.0) 0.0 (21.0–2.0)* 2.0 (0.0–4.0)* ,0.0001
Worsening DSOFA D3 68 (36.0) 92 (56.8)*** 10 (76.9)** ,0.0001
Lactate at admission 17.0 (11.0–30.0) 17.0 (11.9–28.8) 24.0 (16.0–55.0)*{ 0.035
Lactate $20 mg/dL 71 (47.7) 55 (49.1) 18 (66.7) 0.181
Comorbidities 158 (72.5) 134 (81.2) 25 (80.6) 0.116
COPD 32 (14.7) 23 (13.9) 5 (16.1) 0,944
Arterial hypertension 85 (39.0) 70 (42.4) 13 (41.9) 0.784
CRF 24 (11.00) 31 (18.8)* 2 (6.5) 0.043
Immunosuppression 40 (18.3) 42 (25.5) 10 (32.3) 0.100
Diabetes mellitus 50 (22.9) 47 (28.5) 8 (25.8) 0.465
Alcoholism 14 (6.5) 11 (6.7) 1 (3.2) 0.759
Admission category
Clinical 141 (64.7) 116 (70.3) 20 (64.5) 0.490
Surgical 77 (35.3) 49 (29.7) 11 (35.5)
Sepsis category
Severe sepsis 70 (32.1) 54 (32.7) 5 (16.1) 0.138
Septic shock 148 (67.9) 111 (67.3) 26 (83.9)
Infection category
Community acquired 137 (62.8) 56 (33.9)*** 12 (38.7)* ,0.0001
Hospital acquired 81 (37.2) 109 (66.1) 19 (61.3)
Source of infection
Pulmonary 100 (45.9) 95 (57.6)* 13 (41.9) 0.048
Abdominal 49 (22.5) 38 (23.0) 10 (32.3) 0.503
UTI 32 (14.7) 8 (4.8) *** 2 (6.5) 0.005
Organ dysfunction (n) 3.0 (2.0–3.0) 3.0 (2.0–3.0) 3.0 (2.0–4.0) 0.369
Dysfunction .2 113 (51.8) 91 (55.2) 20 (64.5) 0.386
Type of dysfunction
Cardiovascular 198 (90.8) 148 (89.7) 29 (93.5) 0.784
Respiratory 97 (44.5) 95 (57.6)* 21 (67.7)* 0.006
Renal 87 (39.9) 78 (47.3) 15 (48.4) 0.301
Metabolic 46 (21.1) 32 (19.4) 12 (38.7) 0.076
Hematologic 43 (19.7) 38 (23.0) 8 (25.8) 0.617
Hepatic 25 (11.5) 25 (15.2) 12 (38.7)*** {{ ,0.0001
Neurologic 59 (27.1) 60 (36.4) 10 (32.3) 0.150
APACHE: Acute Physiological and Chronic Health Evaluation; SOFA D0: Sequential Organ Failure Assessment at admission; ICU: intensive care unit; COPD:
chronic obstructive pulmonary disease; CRF: chronic renal failure; UTI: urinary tract infection. The results are expressed as the number (%) or median
(25%–75% percentile). +Chi-squared and Kruskal-Wallis tests. Chi-squared partition or Muller-Dunn post-test: * p#0.05 vs. Group 1; ** p#0.01 vs. Group 1;
*** p#0.001 vs. Group 1; { p#0.05 vs. Group 2; {{ p#0.01 vs. Group 2; {{{ p#0.001 vs. Group 2.
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higher for early death. The illness severity at admission
(APACHE II) and hepatic dysfunction were only correlated
with early death, while Black race and a source of infection
other than the urinary tract were only correlated with late
death. When the risk factors for early death were analyzed
among the non-survivors, APACHE II, chronic renal failure,
hepatic dysfunction, and the SOFA score after 24 hours and
duration of organ dysfunction were identified. The results
of the multinomial analysis are shown in Table 3. The lactate
level was not included in the primary multinomial analysis,
as there were too many missing values (n = 55). A secondary
multinomial analysis that included the lactate levels
categorized according to the ROC curve did not change
the results (data not shown).
Table 2 - Characteristics related to adequate treatment and organ dysfunction evolution according to the survival
group.
Variable Group 1 (n = 218) Group 2 (n= 165) Group 3 (n= 31) p-value+
Duration of organ dysfunction
(hours)
2.2 (0.0–9.6) 6.0 (0.0–15.0)* 6.0 (1.6–9.0) 0.019
Duration of organ dysfunction
.1 hour
128 (59.3) 115 (70.1)* 26 (83.9)** 0.005
6-hour bundle compliance
Lactate sampling 137 (62.8) 106 (64.2) 24 (77.4) 0.283
Blood culture sampling 117 (53.9) 76 (46.1) 14 (45.2) 0.266
Antibiotics
Up to 1 hour 129 (59.2) 87 (52.7) 19 (61.3) 0.392
Time to antibiotics (h) 2.0 (0.62–6.0) 2.64 (1.0–6.0) 1.25 (0.5–5.0) 0.319
Volume/vasopressors 191 (97.0) 143 (96.6) 29 (96.7) 0.981
CVP achievement 67 (45.9) 51 (45.1) 17 (65.4) 0.154
SvcO2 achievement 76 (52.1) 57 (50.4) 15 (57.7) 0.799
Compliance with all 6 h items 0 0 0 –
24 h bundle compliance
Glycemic control
Median ,180 mg/dL 160 (73.4) 121 (73.3) 20 (64.5) 0.567
Glycemia* 140.0 (120.0–162.0) 143.0 (120.0–167.0) 128.0 (119.0–169.0) 0.648
Hypoglycemia** 15 (6.9) 11 (6.7) 4 (12.9) 0.457
Plato pressure
Median ,30 cmH2O 117 (89.3) 112 (91.1) 21 (87.5) 0.825
Median 24.0 (20.0–27.0) 25.5 (22.0–28.0)* 25.0 (22.0–28.0) 0.020
Median .24 cmH2O 67 (51.1) 82 (66.1)* 16 (69.6) 0.030
CVP: central venous pressure; SvcO2: central venous oxygen saturation; SOFA: Sequential Organ Failure Assessment; D: day; *median value between the
6th and 24th hours; ** patients with at least 1 episode of hypoglycemia. The results are expressed as the number (%) or median (25%–75% percentile).
+Chi-squared and Kruskal-Wallis tests. Chi-squared partition or Muller-Dunn post-test: *p#0.05 vs. Group 1; **p#0.01 vs. Group 1; ***p#0.001 vs. Group
1; {p#0.05 vs. Group 2; {{p#0.01 vs. Group 2; {{{p#0.001 vs. Group 2.
Table 3 - Risk factors related to early and late death – multinomial analysis.
Variable p-value OR (95% CI)
Factors related to early death (Group 1 vs. Group 3)
Duration of organ dysfunction .1 hour 0.003 6.289 (1.886–20.833)
SOFA D1 $ 8 ,0.0001 8.333 (2.610–26.315)
Age $52 years 0.058 3.225 (0.961–45.933)
Hospital-acquired infection 0.030 2.808 (1.102–7.142)
APACHE $22 0.013 3.389 (1.292–8.850)
Hepatic dysfunction 0.001 5.988 (2.164–16.666)
Factors related to late death (Group 1 vs. Group 2)
Duration of organ dysfunction . 1 hour 0.025 1.764 (1.075–2.899)
SOFA D1 $8 ,0.0001 2.632 (1.639–4.219)
Age $52 years 0.003 2.370(1.345–4.184)
Hospital-acquired infection ,0.0001 2.950 (1.851–4.695)
Urinary tract infection 0.024 0.362 (0.150–0.8741)
Black race 0.013 2.304 (1.191–4.464)
Factors related to early death among non-survivors (Group 2 vs. Group 3)
Duration of organ dysfunction .1 hour 0.024 3.953 (1.195–13.080)
SOFA D1 $8 0.037 3.406 (1.077–10.771)
APACHE $22 0.043 2.610 (1.030–6.615)
Hepatic dysfunction 0.001 4.776 (1.833–12.445)
Chronic renal failure 0.040 0.188 (0.038–0.923)
APACHE: Acute Physiological and Chronic Health Evaluation; SOFA D1: Sequential Organ Failure Assessment at Day 1; OR: odds ratio; CI: confidence
interval. Multinomial analysis.
CLINICS 2013;68(5):586-591 Determinants of early death in sepsis
Machado FR et al.
589
& DISCUSSION
This study showed that both illness severity and early
recognition were associated with early death. In the multi-
nomial analysis, we demonstrated that the APACHE II
score, presence of chronic renal failure, sepsis-induced
hepatic dysfunction, duration of organ dysfunction, and
SOFA score in the first day after initial organ dysfunction
were able to distinguish early non-survivors from late non-
survivors. We also demonstrated that compared with the
survivors, early death was associated with age, illness
severity at admission (APACHE II), illness severity on the
first day (SOFA D1), and hospital-acquired infection. All of
these issues are well-known risk factors for sepsis mortality.
However, our study identified 2 other risk factors that have
not been frequently described in previous studies: the
presence of hepatic dysfunction and the duration of organ
dysfunction. Both issues were not only risk factors for early
mortality but also identified the patients who would die
early among the non-survivors.
Only 3 studies have focused on earlymortality risk factors in
sepsis patients (8–10). Amulticenter French study showed that
27% of all fatalities occurred in the first 2 days of severe sepsis,
and the illness severity, as assessed by the SAPS II score,
number of organ failures and the presence of shock or acidosis
were associated with death (8). In their study, later mortality
was associated with the underlying disease and chronic liver
and heart failure. Blanco et al. analyzed risk factors related to
death within the first 48 hours, during which 14.8% of all
deaths occurred (9). Neither of these studies included
variables related to the adequacy of treatment or the duration
of organ dysfunction in their analysis. These studies included
patients observed in 1993 and 2002, when the relevance of
early detection and interventionwas not as widely recognized.
This early approach could have impacted early deaths, as we
showed a lower proportion of early death compared to the
previous authors.
The association between hepatic dysfunction and early
death that was found in our study and by Blanco et al. is
interesting. We assessed acute hepatic dysfunction related
to sepsis and not chronic hepatic failure, which has already
been described to be associated with late death (8). There are
multiple possible explanations for this finding. First, liver
dysfunction has been associated with the inability of the
immune system to adequately react to host invasion by
pathogenic organisms (16–18). Indeed, infected patients
with chronic or acute liver dysfunction present with worse
prognoses (19). Second, the liver is also responsible for
coagulation factor synthesis, and its impairment is clearly
related to prognosis (20,21). Activated prothrombin time
and fibrinogen level can be predictors of early death (12).
Finally, liver impairment is a neglected dysfunction in
sepsis; thus, other studies might not have found this
association simply because they did not evaluate it.
Non-compliance with the SSC bundles was not related to
early or late death. This finding contrasts with other studies,
which have shown a clear association between SSC bundle
adherence and survival (22–27). A possible explanation is
that patients who will die earlier could appear sicker at
inclusion and are thus more prone to receive early and
adequate care, which is not enough to permit survival in the
face of severe disease. Another explanation is that we
evaluated compliance at the time of sepsis diagnosis. In
Brazil, the time between the onset of organ dysfunction and
a proper sepsis diagnosis can be long (28). In this context,
the compliance measure after diagnosis would not reflect
the appropriateness of the treatment.
One of the most important contributions of this study was
to clearly demonstrate that the delay in diagnosis and,
consequently, treatment was related to not only death but
also early death among non-survivors. Although previous
studies have already addressed this issue (28–30), they did
not associate these delays with early death. Moreover, in our
study, the best cut-off value for predicting death was
1 hour. The impact of small delays has already been
demonstrated. Kumar et al. showed that the mortality of
septic shock patients increased after delaying adequate
antibiotic administration (31) by only 1 hour. Thus, it is
unsurprising that even small delays in sepsis recognition
could have substantial impacts on both global mortality and
early mortality.
Another interesting finding was the association between
lactate level and the risk of early death. Although this
association could not be tested in an appropriate multi-
nomial analysis because of excessive missing values, high
lactate and its non-clearance are clearly associated with
mortality (27,32–34). However, this is the first study to show
that high lactate is associated with early mortality, even
when only non-survivors are considered.
There are strengths and limitations to our study. One of
its strengths is its multicentric nature, which comprised
both private and public hospitals. Second, we used a strict
definition of ‘‘early death’’ that considered the initiation of
organ dysfunction in addition to diagnosing sepsis or ICU
admissions. Third, we obtained robust data that was related
to the specific therapeutic actions of the clinical team based
on the SSC bundles. Although they were not related to
mortality, most likely because of the long time between the
initiation of organ dysfunction and adequate treatment, we
provided an unprecedented analysis of the early mortality
risk factors. Fourth, our multinomial analysis allowed us to
clearly identify the risk factors for early or late death as well
as the risk factors for early death among non-survivors.
One of our study limitations was the absence of
information on withholding or withdrawal of life support,
primarily in the early death group. However, as palliative
care patients were not included, any initiative to stop life
support would most likely reflect the severity of sepsis and
not the severity of the underlying disease, for which
palliative care would be advisable. Another weakness was
the lack of information on causes of death. We should also
consider the potential interaction between the presence of
liver dysfunction and the SOFA score as a limitation.
However, our covariance analysis using the Jaccard test
did not show the presence of collinearity.
In summary, in a large, multicenter severe sepsis
database, both the severity of disease and late recognition
of sepsis were associated with early death.
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